Bhushan Akshikar Appointed as President of OPPI to Enhance Healthcare Access and Innovation

Thursday, 26 September 2024, 04:23

Bhushan Akshikar appointed as President of OPPI marks a significant milestone for the pharmaceutical industry. With over 13 years of experience in leadership roles at GSK, he aims to enhance access through innovation. His extensive background promises to strengthen OPPI’s mission in collaboration with the Government of India for a sustainable healthcare future.
Financialexpress
Bhushan Akshikar Appointed as President of OPPI to Enhance Healthcare Access and Innovation

Bhushan Akshikar Appointed as President of OPPI

The Organisation of Pharmaceutical Producers of India (OPPI) on Thursday announced that it has appointed Bhushan Akshikar as its President for a term of two years effective 26th September 2024. According to the organisation, Bhushan is a seasoned business leader and has an experience of over 13 years in key leadership roles in GSK across India, Middle East, Russia CIS & Africa region.

Bhushan stated, “I am excited and humbled to lead OPPI’s vision to collaborate with the Government of India to enhance access with innovation for patients, at such a crucial time for healthcare in our country. Over the years, OPPI’s focus has been on collective action to forge a path towards a more inclusive, innovative, and sustainable healthcare future for our country.”

Experience in the Pharmaceutical Sector

Before joining GSK, Bhushan spent 15 years with Janssen, Johnson & Johnson, in local and regional positions in India, South Korea and Belgium. Bhushan expressed his heartfelt gratitude to Suresh for his steadfast dedication to advancing OPPI’s vision of enabling a healthier India through innovative solutions. He added, “We look forward to his continued guidance. I am thrilled to welcome Bhushan to his new role. His extensive experience and thought leadership in the pharmaceutical industry will be invaluable as OPPI continues to support the nation’s healthcare objectives with a patient-centric approach.”

Anil Matai, Director General OPPI, emphasized, “Bhushan has consistently been a strong advocate for healthcare transformation in our country. Under his leadership, we are confident to enhance our efforts to optimize patient outcomes by fostering an environment that encourages innovation and growth.”


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most accurate and current medical news. Stay updated and deepen your understanding of medical advancements effortlessly.

Subscribe